CONMED Corporation Appoints Peter Shagory as Executive Vice President, Strategy and Corporate Development

UTICA, N.Y.--()--CONMED Corporation (NASDAQ:CNMD) today announced that it has appointed Peter Shagory as the Company’s Executive Vice President, Strategy and Corporate Development. Mr. Shagory will be responsible for managing CONMED’s global business development and strategic business opportunities.

“I am thrilled to join CONMED during this exciting period in the Company’s history, and I look forward to being a part of shaping CONMED’s growth strategy and enhancing the Company’s profile around the world.”

Mr. Shagory brings to CONMED more than 20 years of experience in healthcare venture investing and mergers and acquisitions through his previous venture capital, investment banking and corporate roles.

Most recently, Mr. Shagory led the strategy and business development efforts for Cardinal Health’s Medical Products Group within the Medical Segment, where he played a key role in Cardinal Health’s entry into the interventional cardiovascular and the advanced wound care categories. Prior to that, Mr. Shagory led the healthcare and life sciences investment effort at Baird Venture Partners, focusing on medical technology and research tools and diagnostics.

“We are very pleased to welcome Pete to CONMED’s executive team. His deep understanding of business development strategies and his investment expertise will be invaluable as we continue to build on our position as an innovative leader in the medical device industry,” commented Curt R. Hartman, CONMED’s President and Chief Executive Officer.

Peter Shagory said, “I am thrilled to join CONMED during this exciting period in the Company’s history, and I look forward to being a part of shaping CONMED’s growth strategy and enhancing the Company’s profile around the world.”

Mr. Shagory earned an MBA from Dartmouth’s Tuck School of Business and a BS in Finance from Miami University in Oxford, Ohio.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company distributes its products worldwide from several manufacturing locations. CONMED has a direct selling presence in 16 countries outside the United States, and international sales constitute over 50% of the Company’s total sales. Headquartered in Utica, New York, the Company employs 3,400 people. For more information, visit www.conmed.com.

Forward Looking Information

This press release contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's performance on a going-forward basis. The forward-looking statements in this press release involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. In addition to general industry and economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this press release include, but are not limited to the risks relating to forward-looking statements discussed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

Contacts

CONMED Corporation
Luke Pomilio, 315-624-3202
Chief Financial Officer

Recent Stories

RSS feed for CONMED Corporation

CONMED Corporation